Bioanalytical methods guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA issues draft guidance for analytical methods validation in pharmacokinetics, bioequivalence and bioavailability studies. The document covers procedures for demonstrating the reliability of quantitative measurements of analyte in a biological matrix. Comments may be submitted through March 8